Agron Plevneshi

Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007-2024.

A. Li, Maxime Lefebvre, Zoe Zhong, H. Almohri +38 more

2026Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada0 citations Open access

Semantic Scholar

Agron Plevneshi

Most-cited papers

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada.

Sensitivity of Nasopharyngeal Swabs and Saliva for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2

Invasive Pneumococcal Disease in Solid Organ Transplant Recipients—10‐Year Prospective Population Surveillance

Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance

Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.

Population-Based Surveillance for Invasive Pneumococcal Disease in Homeless Adults in Toronto

Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia

Invasive Group A Streptococcal Infection in Children, 1992-2023

Canada-Wide Epidemic of emm74 Group A Streptococcus Invasive Disease

When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto

Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003-2011.

Burden of Severe Illness Associated With Laboratory-Confirmed Influenza in Adults Aged 50–64 Years, 2010–2011 to 2016–2017

Evolving genomic landscape of pediatric pneumococcus in two Canadian urban centers following conjugate vaccination

Factors Associated With 30-Day Mortality Rate in Respiratory Infections Caused by Streptococcus pneumoniae

Prevalence of and risk factors for antimicrobial resistance in pneumococcal disease in southern Ontario during the PCV13 era.

Changing Epidemiology of Invasive Pneumococcal Disease due to Conjugate Vaccine Serotypes in Toronto, Canada After Introduction of a Routine Pediatric PCV13 Program

Invasive Pneumococcal Disease (IPD) in Children and Adults Following Introduction of Pneumococcal Conjugate Vaccines: Data From Population Based Surveillance 2001–2015

Invasive Group A Streptococcal Infections in Ontario, Canada: 1992–2013

Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007-2024.

2606. Epidemiology of invasive pneumococcal disease in adults with and without underlying lung disease in Ontario, Canada

1309. Incidence and Epidemiology of Invasive Pneumococcal Disease due to Serotype 3 in South-Central Ontario

295. Is Herd Immunity from Pneumococcal Conjugate Vaccines Changing the Clinical Features of Invasive Pneumococcal Disease in Adults?

2716. Persistence of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Serotypes in Invasive Pneumococcal Disease in Adults in Southern Ontario Canada Despite Routine Pediatric Vaccination

462. Prospective Surveillance of Invasive Group A Streptococcal Infections in Toronto, Ontario, Canada: 1992–2017

1426. Impact of Routine Pediatric PCV13 on the Incidence and Severity of Invasive Pneumococcal Disease in Adults in Ontario, Canada

2401. Risk Factors for Antimicrobial Resistance in Invasive Pneumococcal disease (IPD) in Toronto, Canada, 2012–2017

Burden of Hospitalization Associated with Seasonal Influenza in Toronto, Canada, 2011-2016

Seroepidemiology of invasive pneumococcal disease in patients with chronic obstuctive pulmonary disease (COPD), Toronto, Canada

Incidence of Invasive Pneumococcal Disease (IPD) post Pneumococcal Conjugate Vaccines in Toronto/Peel, Canada, 2001–2015

Factors Associated with Mortality in Severe Disease Due to Influenza in Adults in Toronto, Canada, 2005-2008